Cerus lands additional $15m in government funding

Cerus (NSDQ:CERS) landed a $15 million amendment to its contract with the U.S. Dept. of Health & Human Services’ Biomedical Advanced Research and Development Authority, bringing the total potential value of its deal to $201 million. The expanded agreement is designed to support additional clinical trials of the company’s Intercept blood transfusion technology. Get the full story at our sister site, Drug Delivery Business News. The post Cerus lands additional $15m in government funding appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Funding Roundup Surgical Wall Street Beat Cerus Corp. Source Type: news